Access to substance abuse treatment services under the Oregon Health Plan

Dennis D. Deck, Bentson McFarland, Jessica M. Titus, Katherine E. Laws, Roy M. Gabriel

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Context: The shift to Medicaid managed care has raised numerous concerns about access to publicly funded substance abuse treatment. The implementation of a capitated chemical dependency benefit within the Oregon Health Plan in 1995 provided an opportunity to study the impact of funding mechanisms on access. Objectives: To determine to what extent access to publicly funded substance abuse treatment changed following the shift to managed care in Oregon and to examine factors associated with that change. Design: Analysis of statewide treatment and Medicaid eligibility data. Setting and Patients: All Medicaid-eligible persons aged 12 to 64 years who were enrolled in the Oregon Health Plan during 1994 (88320), 1996 (170387), 1997 (160929), or 1998 (149877). Main Outcome Measures: Access rates (the number of unique individuals admitted to treatment during a calendar year divided by the average number of enrolled members) computed before (1994) and after (1997) implementation of the capitated benefit. Analyses were replicated with data for 1996 and 1998. Results: The percentage of Medicaid-eligible persons admitted to substance abuse treatment programs during a calendar year increased from 5.5% of the average number of enrolled members per month in 1994 to 7.7% in 1997, following the shift to managed care. For 1996 and 1998, the rates were 6.9% and 7.7%, respectively. Access rates varied considerably among the 7 largest prepaid health plans after adjusting for case mix. Operating characteristics of these prepaid health plans, such as the method of reimbursing treatment providers, were significant predictors of access after controlling for member characteristics. Conclusion: According to our analyses, Medicaid-eligible persons in Oregon observed an increase in access to substance abuse treatment after a shift to managed care.

Original languageEnglish (US)
Pages (from-to)2093-2099
Number of pages7
JournalJournal of the American Medical Association
Volume284
Issue number16
StatePublished - Oct 25 2000

Fingerprint

Substance-Related Disorders
Medicaid
Managed Care Programs
Health
Prepaid Health Plans
Therapeutics
Diagnosis-Related Groups
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Deck, D. D., McFarland, B., Titus, J. M., Laws, K. E., & Gabriel, R. M. (2000). Access to substance abuse treatment services under the Oregon Health Plan. Journal of the American Medical Association, 284(16), 2093-2099.

Access to substance abuse treatment services under the Oregon Health Plan. / Deck, Dennis D.; McFarland, Bentson; Titus, Jessica M.; Laws, Katherine E.; Gabriel, Roy M.

In: Journal of the American Medical Association, Vol. 284, No. 16, 25.10.2000, p. 2093-2099.

Research output: Contribution to journalArticle

Deck, DD, McFarland, B, Titus, JM, Laws, KE & Gabriel, RM 2000, 'Access to substance abuse treatment services under the Oregon Health Plan', Journal of the American Medical Association, vol. 284, no. 16, pp. 2093-2099.
Deck DD, McFarland B, Titus JM, Laws KE, Gabriel RM. Access to substance abuse treatment services under the Oregon Health Plan. Journal of the American Medical Association. 2000 Oct 25;284(16):2093-2099.
Deck, Dennis D. ; McFarland, Bentson ; Titus, Jessica M. ; Laws, Katherine E. ; Gabriel, Roy M. / Access to substance abuse treatment services under the Oregon Health Plan. In: Journal of the American Medical Association. 2000 ; Vol. 284, No. 16. pp. 2093-2099.
@article{ad5a56317c274a8d91a97d752cdb7e80,
title = "Access to substance abuse treatment services under the Oregon Health Plan",
abstract = "Context: The shift to Medicaid managed care has raised numerous concerns about access to publicly funded substance abuse treatment. The implementation of a capitated chemical dependency benefit within the Oregon Health Plan in 1995 provided an opportunity to study the impact of funding mechanisms on access. Objectives: To determine to what extent access to publicly funded substance abuse treatment changed following the shift to managed care in Oregon and to examine factors associated with that change. Design: Analysis of statewide treatment and Medicaid eligibility data. Setting and Patients: All Medicaid-eligible persons aged 12 to 64 years who were enrolled in the Oregon Health Plan during 1994 (88320), 1996 (170387), 1997 (160929), or 1998 (149877). Main Outcome Measures: Access rates (the number of unique individuals admitted to treatment during a calendar year divided by the average number of enrolled members) computed before (1994) and after (1997) implementation of the capitated benefit. Analyses were replicated with data for 1996 and 1998. Results: The percentage of Medicaid-eligible persons admitted to substance abuse treatment programs during a calendar year increased from 5.5{\%} of the average number of enrolled members per month in 1994 to 7.7{\%} in 1997, following the shift to managed care. For 1996 and 1998, the rates were 6.9{\%} and 7.7{\%}, respectively. Access rates varied considerably among the 7 largest prepaid health plans after adjusting for case mix. Operating characteristics of these prepaid health plans, such as the method of reimbursing treatment providers, were significant predictors of access after controlling for member characteristics. Conclusion: According to our analyses, Medicaid-eligible persons in Oregon observed an increase in access to substance abuse treatment after a shift to managed care.",
author = "Deck, {Dennis D.} and Bentson McFarland and Titus, {Jessica M.} and Laws, {Katherine E.} and Gabriel, {Roy M.}",
year = "2000",
month = "10",
day = "25",
language = "English (US)",
volume = "284",
pages = "2093--2099",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "16",

}

TY - JOUR

T1 - Access to substance abuse treatment services under the Oregon Health Plan

AU - Deck, Dennis D.

AU - McFarland, Bentson

AU - Titus, Jessica M.

AU - Laws, Katherine E.

AU - Gabriel, Roy M.

PY - 2000/10/25

Y1 - 2000/10/25

N2 - Context: The shift to Medicaid managed care has raised numerous concerns about access to publicly funded substance abuse treatment. The implementation of a capitated chemical dependency benefit within the Oregon Health Plan in 1995 provided an opportunity to study the impact of funding mechanisms on access. Objectives: To determine to what extent access to publicly funded substance abuse treatment changed following the shift to managed care in Oregon and to examine factors associated with that change. Design: Analysis of statewide treatment and Medicaid eligibility data. Setting and Patients: All Medicaid-eligible persons aged 12 to 64 years who were enrolled in the Oregon Health Plan during 1994 (88320), 1996 (170387), 1997 (160929), or 1998 (149877). Main Outcome Measures: Access rates (the number of unique individuals admitted to treatment during a calendar year divided by the average number of enrolled members) computed before (1994) and after (1997) implementation of the capitated benefit. Analyses were replicated with data for 1996 and 1998. Results: The percentage of Medicaid-eligible persons admitted to substance abuse treatment programs during a calendar year increased from 5.5% of the average number of enrolled members per month in 1994 to 7.7% in 1997, following the shift to managed care. For 1996 and 1998, the rates were 6.9% and 7.7%, respectively. Access rates varied considerably among the 7 largest prepaid health plans after adjusting for case mix. Operating characteristics of these prepaid health plans, such as the method of reimbursing treatment providers, were significant predictors of access after controlling for member characteristics. Conclusion: According to our analyses, Medicaid-eligible persons in Oregon observed an increase in access to substance abuse treatment after a shift to managed care.

AB - Context: The shift to Medicaid managed care has raised numerous concerns about access to publicly funded substance abuse treatment. The implementation of a capitated chemical dependency benefit within the Oregon Health Plan in 1995 provided an opportunity to study the impact of funding mechanisms on access. Objectives: To determine to what extent access to publicly funded substance abuse treatment changed following the shift to managed care in Oregon and to examine factors associated with that change. Design: Analysis of statewide treatment and Medicaid eligibility data. Setting and Patients: All Medicaid-eligible persons aged 12 to 64 years who were enrolled in the Oregon Health Plan during 1994 (88320), 1996 (170387), 1997 (160929), or 1998 (149877). Main Outcome Measures: Access rates (the number of unique individuals admitted to treatment during a calendar year divided by the average number of enrolled members) computed before (1994) and after (1997) implementation of the capitated benefit. Analyses were replicated with data for 1996 and 1998. Results: The percentage of Medicaid-eligible persons admitted to substance abuse treatment programs during a calendar year increased from 5.5% of the average number of enrolled members per month in 1994 to 7.7% in 1997, following the shift to managed care. For 1996 and 1998, the rates were 6.9% and 7.7%, respectively. Access rates varied considerably among the 7 largest prepaid health plans after adjusting for case mix. Operating characteristics of these prepaid health plans, such as the method of reimbursing treatment providers, were significant predictors of access after controlling for member characteristics. Conclusion: According to our analyses, Medicaid-eligible persons in Oregon observed an increase in access to substance abuse treatment after a shift to managed care.

UR - http://www.scopus.com/inward/record.url?scp=0034715564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034715564&partnerID=8YFLogxK

M3 - Article

C2 - 11042758

AN - SCOPUS:0034715564

VL - 284

SP - 2093

EP - 2099

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 16

ER -